Trial Profile
Effects of cholesterol reduction by simvastatin and ezetimibe on muscle sympathetic nerve activity in hypertension and hypercholesterolaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 May 2013
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Hypercholesterolaemia; Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 29 May 2013 New trial record
- 18 May 2013 Results presented at the 28th Annual Scientific Meeting of the American Society of Hypertension.